Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
J Am Soc Nephrol
    June 2021
  1. WEI J, Zhang J, Jiang S, Xu L, et al
    Macula Densa NOS1beta Modulates Renal Hemodynamics and Blood Pressure During Pregnancy: Role in Gestational Hypertension.
    J Am Soc Nephrol. 2021 Jun 14. pii: ASN.2020070969. doi: 10.1681/ASN.2020070969.
    >> Share

    February 2021
  2. HARUHARA K, Sasaki T, de Zoysa N, Okabayashi Y, et al
    Podometrics in Japanese Living Donor Kidneys: Associations with Nephron Number, Age, and Hypertension.
    J Am Soc Nephrol. 2021 Feb 24. pii: ASN.2020101486. doi: 10.1681/ASN.2020101486.
    >> Share

    January 2021
  3. AYUZAWA N, Fujita T
    The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury.
    J Am Soc Nephrol. 2021 Jan 4. pii: ASN.2020071041. doi: 10.1681/ASN.2020071041.
    >> Share

  4. SHETTY AA, Tawhari I, Safar-Boueri L, Seif N, et al
    COVID-19-Associated Glomerular Disease.
    J Am Soc Nephrol. 2021;32:33-40.
    >> Share

    December 2020
  5. GUPTA A, Burns JM
    A Single Point-in-Time eGFR Is Not Associated with Increased Risk of Dementia in the Elderly.
    J Am Soc Nephrol. 2020;31:2965.
    >> Share

  6. KURELLA TAMURA M, Pajewski N, Weiner DE
    Authors' Reply.
    J Am Soc Nephrol. 2020;31:2966.
    >> Share

    September 2020
  7. RAHMAN M, Wang X, Bundy JD, Charleston J, et al
    Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Sep 24. pii: ASN.2020030236. doi: 10.1681/ASN.2020030236.
    >> Share

  8. JOO YS, Lee C, Kim HW, Jhee J, et al
    Association of Longitudinal Trajectories of Systolic BP with Risk of Incident CKD: Results from the Korean Genome and Epidemiology Study.
    J Am Soc Nephrol. 2020;31:2133-2144.
    >> Share

    July 2020
  9. FERGUSON R, Leatherman S, Fiore M, Minnings K, et al
    Prevalence and Risk Factors for CKD in the General Population of Southwestern Nicaragua.
    J Am Soc Nephrol. 2020;31:1585-1593.
    >> Share

    June 2020
  10. KURELLA TAMURA M, Gaussoin SA, Pajewski NM, Chelune GJ, et al
    Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
    J Am Soc Nephrol. 2020 Jun 26. pii: ASN.2020010038. doi: 10.1681/ASN.2020010038.
    >> Share

  11. CHENG Y, Wang D, Wang F, Liu J, et al
    Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
    J Am Soc Nephrol. 2020 Jun 2. pii: ASN.2019101100. doi: 10.1681/ASN.2019101100.
    >> Share

    April 2020
  12. AYUZAWA N, Nishimoto M, Ueda K, Hirohama D, et al
    Two Mineralocorticoid Receptor-Mediated Mechanisms of Pendrin Activation in Distal Nephrons.
    J Am Soc Nephrol. 2020;31:748-764.
    >> Share

  13. FAN F, Geurts AM, Pabbidi MR, Ge Y, et al
    A Mutation in gamma-Adducin Impairs Autoregulation of Renal Blood Flow and Promotes the Development of Kidney Disease.
    J Am Soc Nephrol. 2020;31:687-700.
    >> Share

    March 2020
  14. DHANDE IS, Doris PA
    Pulling the Hood off Genetic Susceptibility to Hypertensive Renal Disease.
    J Am Soc Nephrol. 2020 Mar 2. pii: ASN.2020020139. doi: 10.1681/ASN.2020020139.
    >> Share

    February 2020
  15. HERING L, Rahman M, Hoch H, Marko L, et al
    alpha2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease.
    J Am Soc Nephrol. 2020 Feb 21. pii: ASN.2019060599. doi: 10.1681/ASN.2019060599.
    >> Share

  16. BIDANI AK, Polichnowski AJ, Licea-Vargas H, Long J, et al
    BP Fluctuations and the Real-Time Dynamics of Renal Blood Flow Responses in Conscious Rats.
    J Am Soc Nephrol. 2020;31:324-336.
    >> Share

    January 2020
  17. BOVEE DM, Visser WJ, Middel I, De Mik-van Egmond A, et al
    A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.
    J Am Soc Nephrol. 2020 Jan 29. pii: ASN.2019090905. doi: 10.1681/ASN.2019090905.
    >> Share

    September 2019
  18. SHAH S, Christianson AL, Meganathan K, Leonard AC, et al
    Racial Differences and Factors Associated with Pregnancy in End Stage Kidney Disease Patients on Dialysis in the United States.
    J Am Soc Nephrol. 2019 Sep 25. pii: ASN.2019030234. doi: 10.1681/ASN.2019030234.
    >> Share

  19. WAN EYF, Yu EYT, Chin WY, Fong DYT, et al
    Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients.
    J Am Soc Nephrol. 2019 Sep 6. pii: ASN.2018101037. doi: 10.1681/ASN.2018101037.
    >> Share

    April 2019
  20. ABDEL KHALEK W, Rafael C, Loisel-Ferreira I, Kouranti I, et al
    Severe Arterial Hypertension from Cullin 3 Mutations Is Caused by Both Renal and Vascular Effects.
    J Am Soc Nephrol. 2019 Apr 9. pii: ASN.2017121307. doi: 10.1681/ASN.2017121307.
    >> Share

    March 2019
  21. ISHIZAWA K, Wang Q, Li J, Xu N, et al
    Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice.
    J Am Soc Nephrol. 2019 Mar 26. pii: ASN.2018070703. doi: 10.1681/ASN.2018070703.
    >> Share

  22. SHROFF R, Smith C, Ranchin B, Bayazit AK, et al
    Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.
    J Am Soc Nephrol. 2019 Mar 7. pii: ASN.2018100990. doi: 10.1681/ASN.2018100990.
    >> Share

    December 2018
  23. MCCULLOUGH KP, Morgenstern H, Saran R, Herman WH, et al
    Projecting ESRD Incidence and Prevalence in the United States through 2030.
    J Am Soc Nephrol. 2018 Dec 17. pii: ASN.2018050531. doi: 10.1681/ASN.2018050531.
    >> Share

    July 2018
  24. LIU Y, Usa K, Wang F, Liu P, et al
    MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.
    J Am Soc Nephrol. 2018 Jul 26. pii: ASN.2018020117. doi: 10.1681/ASN.2018020117.
    >> Share

    June 2018
  25. TIMMERMANS SAMEG, Abdul-Hamid MA, Potjewijd J, Theunissen ROMFIH, et al
    C5b9 Formation on Endothelial Cells Reflects Complement Defects among Patients with Renal Thrombotic Microangiopathy and Severe Hypertension.
    J Am Soc Nephrol. 2018 Jun 1. pii: ASN.2018020184. doi: 10.1681/ASN.2018020184.
    >> Share

    December 2017
  26. MISKULIN DC, Gassman J, Schrader R, Gul A, et al
    BP in Dialysis: Results of a Pilot Study.
    J Am Soc Nephrol. 2017 Dec 6. pii: ASN.2017020135. doi: 10.1681/ASN.2017020135.
    >> Share

    November 2017
  27. FENG W, Chen B, Xing D, Li X, et al
    Haploinsufficiency of the Transcription Factor Ets-1 Is Renoprotective in Dahl Salt-Sensitive Rats.
    J Am Soc Nephrol. 2017;28:3239-3250.
    >> Share

    October 2017
  28. HARLAN SM, Heinz-Taheny KM, Sullivan JM, Wei T, et al
    Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    J Am Soc Nephrol. 2017 Oct 23. pii: ASN.2017040385. doi: 10.1681/ASN.2017040385.
    >> Share

  29. GIGLIOTTI JC, Le TH
    Ets in the Kidney-Unraveling the Molecular Mechanism Underlying Renal Damage in Salt-Sensitive Hypertension.
    J Am Soc Nephrol. 2017 Oct 16. pii: ASN.2017080917. doi: 10.1681/ASN.2017080917.
    >> Share

  30. FAN F, Roman RJ
    Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.
    J Am Soc Nephrol. 2017;28:2845-2855.
    >> Share

    September 2017
  31. LUQUE Y, Lenoir O, Bonnin P, Hardy L, et al
    Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.
    J Am Soc Nephrol. 2017 Sep 19. pii: ASN.2016090960. doi: 10.1681/ASN.2016090960.
    >> Share

  32. LIU Y, Li H, Liu J, Han P, et al
    Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    J Am Soc Nephrol. 2017 Sep 18. pii: ASN.2015091017. doi: 10.1681/ASN.2015091017.
    >> Share

  33. CHEUNG AK, Rahman M, Reboussin DM, Craven TE, et al
    Effects of Intensive BP Control in CKD.
    J Am Soc Nephrol. 2017;28:2812-2823.
    >> Share

  34. HERMIDA RC, Ayala DE, Mojon A, Fernandez JR, et al
    Sleep-Time Ambulatory BP Is an Independent Prognostic Marker of CKD.
    J Am Soc Nephrol. 2017;28:2802-2811.
    >> Share

    July 2017
  35. MCCORMICK JA, Ellison DH
    Nephron Remodeling Underlies Hyperkalemia in Familial Hyperkalemic Hypertension.
    J Am Soc Nephrol. 2017 Jul 13. pii: ASN.2017060660. doi: 10.1681/ASN.2017060660.
    >> Share

    May 2017
  36. KU E, Bakris G, Johansen KL, Lin F, et al
    Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.
    J Am Soc Nephrol. 2017 May 4. pii: ASN.2017010040. doi: 10.1681/ASN.2017010040.
    >> Share

    April 2017
  37. RAPHAEL KL, Carroll DJ, Murray J, Greene T, et al
    Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease.
    J Am Soc Nephrol. 2017 Apr 6. pii: ASN.2016101151. doi: 10.1681/ASN.2016101151.
    >> Share

  38. YANG T, Xu C
    Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.
    J Am Soc Nephrol. 2017;28:1040-1049.
    >> Share

    January 2017
  39. LENTINE KL, Segev DL
    Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.
    J Am Soc Nephrol. 2017;28:12-24.
    >> Share

    August 2016
  40. KU E, Gassman J, Appel LJ, Smogorzewski M, et al
    BP Control and Long-Term Risk of ESRD and Mortality.
    J Am Soc Nephrol. 2016 Aug 11. pii: ASN.2016030326.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016